|
| Press Releases |
|
 |
|
| Monday, July 8, 2019 |
|
|
Eisai Enters Into Collaboration Research Agreement With University of Dundee on Targeted Protein Degradation Toward Cancer Drug Discovery |
| Eisai Co.,Ltd. has entered into a collaboration research agreement with the University of Dundee in Scotland, UK, regarding Proteolysis Targeting Chimeras (PROTACs)(1) toward drug discovery in oncology area. more info >> |
|
| Tuesday, June 18, 2019 |
|
|
Eisai: Total Synthesis and Nonclinical Study Results of a Novel Anticancer Drug Candidate E7130 |
| Eisai Co., Ltd. announced today that a joint research group including scientists from Eisai and Professor Yoshito Kishi's group of Harvard University has achieved a total synthesis and obtained results of nonclinical studies of the novel compound, E7130, derived from total synthesis of halichondrin. more info >> |
|
|
Eisai to Present Latest Data on Perampanel at 33rd International Epilepsy Congress |
| Eisai Co., Ltd. announced today that the latest data on its antiepileptic drug (AED) perampanel (product name: Fycompa) will be presented at the 33rd International Epilepsy Congress (IEC) to be held from June 22 to 26, 2019 in Bangkok, Thailand. more info >> |
|
| Wednesday, May 29, 2019 |
|
|
Eisai to Present Latest Data on Lemborexant including Integrated Analysis of Phase III Clinical Studies at 33rd Annual Sleep Meeting |
| Eisai Co.,Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") today announced that latest information on lemborexant, an investigational sleep-wake regulation agent being studied for the treatment of multiple sleepwake disorders, including insomnia and Irregular Sleep-Wake Rhythm Disorder (ISWRD) will be presented at the 33rd Annual Meeting of the Associated Professional Sleep Societies (SLEEP 2019), from June 8 to 12 in San Antonio, Texas, the United States. more info >> |
|
| Friday, May 17, 2019 |
|
|
"Science Based Targets (SBT) Initiative" Approves Eisai's Greenhouse Gas Reduction Targets |
| Eisai Co., Ltd. announced today that Eisai has received approval from "Science Based Targets (SBT) Initiative" for Eisai's mid and long-term targets for greenhouse gas (GHG) reduction. more info >> |
|
| Thursday, May 16, 2019 |
|
|
Eisai to Present Data on Oncology Pipeline and Products at 55th Asco Annual Meeting |
| Major poster presentations at this year's meeting include highlights of the latest data from an ongoing Phase I clinical study investigating Eisai's first ADC MORAb-202 in patients with solid tumors in Japan. more info >> |
|
| Friday, May 10, 2019 |
|
|
Eisai Enters Into Licensing Agreement With Medac Concerning Anti-Rheumatic Agent Methotrexate Subcutaneous Injection in Japan |
| Under the agreement, Eisai will obtain exclusive rights to market MTX subcutaneous injection in Japan. Medac will submit a manufacturing and marketing authorization application for the product after conducting a clinical study in Japan. more info >> |
|
|
Eisai: Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 |
| These studies will be conducted with funding from various sources including the United States National Institute on Aging (NIA), part of the National Institutes of Health, and Eisai. more info >> |
|
| Thursday, May 9, 2019 |
|
|
Eisai and Allm Enter Into Capital and Business Alliance Agreement for ICT Healthcare Solutions |
| Eisai Co., Ltd. and Allm Inc. have entered into a capital and business alliance agreement for ICT digital health solutions in various areas as well as regional medical treatment and care. more info >> |
|
|
Eisai Commences Venture Investment Business Aimed at Accelerating Innovation in Drug Creation and Establishment of Ecosystem Platform |
| Eisai Co., Ltd. announced today that the company has commenced a venture investment business for the purpose of excavating innovative technologies, supporting venture businesses with such technologies, and partnering with those businesses in the future, so as to accelerate innovation in drug creation as well as the establishment of ecosystem platform. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Seven HKTDC mega events showcase Asia's creative hub
Apr 11, 2025 16:30 HKT/SGT
|
|
|
Smart Lighting Expo and Spring Lighting Fair attracts some 15,000 global buyers
Apr 11, 2025 15:24 HKT/SGT
|
|
|
Transform Your Social Media Profile into a Sales Catalog with GoDaddy's Show in Bio Tool
Apr 11, 2025 15:06 HKT/SGT
|
|
|
3rd ASEAN Procurement Innovation Summit & Awards 2025 - The Next Frontier in Procurement Excellence
Apr 11, 2025 14:56 HKT/SGT
|
|
|
Mitsubishi Motors Begins Shipping Xforce HEV Model in Thailand
Apr 11, 2025 15:03 JST
|
|
|
Collaboration to Make Engine-Equipped Vehicles Carbon Neutral Using Synthetic Fuel
Apr 11, 2025 14:03 JST
|
|
|
TGR to Launch Evolved GR Yaris
Apr 11, 2025 13:35 JST
|
|
|
Sunshine Insurance: Practicing 'Insurance for the People'
Apr 11, 2025 12:20 HKT/SGT
|
|
|
AEON CREDIT SERVICE (ASIA) COMPANY LIMITED FY2024/25 Revenue Up to HK$1,759.3 million with Net Profit of HK$400.5 million 
Apr 11, 2025 12:19 HKT/SGT
|
|
|
Fujitsu develops employee training platform for Seven-Eleven Japan to accelerate store digitalization
Apr 11, 2025 11:29 JST
|
|
|
Mitsubishi Corporation makes DennoKotsu an equity-method affiliate company, strengthening efforts to address regional transportation challenges
Apr 11, 2025 10:39 JST
|
|
|
JCB Enhances Customer Experience with Expanded Payment Acceptance for App Store and Apple Services in Asia
Apr 11, 2025 10:00 JST
|
|
|
Fujitsu and Headwaters trial on-device generative AI solution to streamline JAL cabin crew workflows
Apr 11, 2025 9:07 JST
|
|
|
Global strategic speakers confirmed to accelerate energy transformation at Japan Energy Summit & Exhibition 2025
Apr 11, 2025 08:03 HKT/SGT
|
|
|
Trading Nations Global Releases Transformative White Paper Empowering a Quantum-Resilient Future Through Collaboration
Apr 11, 2025 07:30 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
